JP2023518268A5 - - Google Patents
Info
- Publication number
- JP2023518268A5 JP2023518268A5 JP2022556250A JP2022556250A JP2023518268A5 JP 2023518268 A5 JP2023518268 A5 JP 2023518268A5 JP 2022556250 A JP2022556250 A JP 2022556250A JP 2022556250 A JP2022556250 A JP 2022556250A JP 2023518268 A5 JP2023518268 A5 JP 2023518268A5
- Authority
- JP
- Japan
- Prior art keywords
- dsrna
- nucleotides
- chain
- antisense
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062991406P | 2020-03-18 | 2020-03-18 | |
| US62/991,406 | 2020-03-18 | ||
| US202063071115P | 2020-08-27 | 2020-08-27 | |
| US63/071,115 | 2020-08-27 | ||
| PCT/US2021/022748 WO2021188661A1 (en) | 2020-03-18 | 2021-03-17 | Oligonucleotides for snca modulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518268A JP2023518268A (ja) | 2023-04-28 |
| JP2023518268A5 true JP2023518268A5 (cg-RX-API-DMAC7.html) | 2024-03-27 |
Family
ID=77772170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556250A Pending JP2023518268A (ja) | 2020-03-18 | 2021-03-17 | Snca調節のためのオリゴヌクレオチド |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210363524A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4121538A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023518268A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230002327A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115777021A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021238326A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022018475A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3171757A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022011536A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021188661A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230416735A1 (en) * | 2022-04-14 | 2023-12-28 | University Of Massachusetts | Oligonucleotides for atn1 modulation |
| US20240052344A1 (en) * | 2022-05-04 | 2024-02-15 | University Of Massachusetts | Oligonucleotides for pms1 modulation |
| JP2025531512A (ja) * | 2022-09-29 | 2025-09-19 | アタランタ セラピューティクス,インコーポレーテッド | アルファシヌクレイン核酸を標的化するsiRNA組成物及び方法 |
| WO2024166019A1 (en) * | 2023-02-08 | 2024-08-15 | Biorchestra Co., Ltd. | Sirna targeting alpha-synuclein and uses thereof |
| CN122374456A (zh) * | 2023-10-20 | 2026-07-10 | 斯帕克医疗有限公司 | 靶向 α 突触核蛋白表达的抑制性核酸 |
| TW202523678A (zh) * | 2023-12-14 | 2025-06-16 | 國立臺灣大學 | CRISPRI標靶α-突觸核蛋白 |
| TW202529779A (zh) * | 2024-01-30 | 2025-08-01 | 大陸商上海舶望製藥有限公司 | 用於抑制突觸核蛋白α(SNCA)基因表達的組合物和方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005045034A2 (en) * | 2003-10-23 | 2005-05-19 | Sirna Therapeutics, Inc. | RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA) |
| WO2008109509A1 (en) * | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting snca gene expression and uses thereof |
| US20090176729A1 (en) * | 2007-12-14 | 2009-07-09 | Alnylam Pharmaceuticals, Inc. | Method of treating neurodegenerative disease |
| US20100275274A1 (en) * | 2009-04-28 | 2010-10-28 | National Yang-Ming University | Mouse model for depression, schizophrenia and alzheimer's disease |
| WO2010141511A2 (en) * | 2009-06-01 | 2010-12-09 | Halo-Bio Rnai Therapeutics, Inc. | Polynucleotides for multivalent rna interference, compositions and methods of use thereof |
| WO2012027713A2 (en) * | 2010-08-26 | 2012-03-01 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibition of snca |
| EP3521451A1 (en) * | 2010-11-17 | 2019-08-07 | Ionis Pharmaceuticals, Inc. | Modulation of alpha synuclein expression |
| EP3929293A3 (en) * | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| RS60762B1 (sr) * | 2015-04-03 | 2020-10-30 | Univ Massachusetts | Oligonukleotidna jedinjenja za ciljane irnk hantingtina |
| WO2017132669A1 (en) * | 2016-01-31 | 2017-08-03 | University Of Massachusetts | Branched oligonucleotides |
| TW202509215A (zh) * | 2018-08-03 | 2025-03-01 | 美商健臻公司 | 針對α-突觸核蛋白的變體RNAi |
| BR112021002440A2 (pt) * | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| JP2025531512A (ja) * | 2022-09-29 | 2025-09-19 | アタランタ セラピューティクス,インコーポレーテッド | アルファシヌクレイン核酸を標的化するsiRNA組成物及び方法 |
-
2021
- 2021-03-17 JP JP2022556250A patent/JP2023518268A/ja active Pending
- 2021-03-17 WO PCT/US2021/022748 patent/WO2021188661A1/en not_active Ceased
- 2021-03-17 CN CN202180035697.4A patent/CN115777021A/zh active Pending
- 2021-03-17 MX MX2022011536A patent/MX2022011536A/es unknown
- 2021-03-17 BR BR112022018475A patent/BR112022018475A2/pt unknown
- 2021-03-17 US US17/204,483 patent/US20210363524A1/en not_active Abandoned
- 2021-03-17 EP EP21771103.5A patent/EP4121538A4/en active Pending
- 2021-03-17 KR KR1020227032663A patent/KR20230002327A/ko active Pending
- 2021-03-17 AU AU2021238326A patent/AU2021238326A1/en active Pending
- 2021-03-17 CA CA3171757A patent/CA3171757A1/en active Pending
-
2024
- 2024-07-01 US US18/760,779 patent/US20250043284A1/en active Pending